Evidence map›Paper›PMID 40661615›Full record

ArticlebioRxiv : the preprint server for biology2025

Occludin Acts as a Dynein Adaptor Regulating Permeability and Collateral Angiogenesis.

Xuwen Liu, Enming J Su, Alyssa Dreffs, John P Gillies, Madeline Merlino, Lu Gao, Julian S Peregoff, Cheng-Mao Lin, Margaret Elizabeth Ross, Morgan E DeSantis and 2 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Xuwen LiuDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.ORCID 0000-0002-0614-8394
Enming J SuDepartment of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
Alyssa DreffsDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.
John P GilliesDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI.
Madeline MerlinoDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.
Lu GaoDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.
Julian S PeregoffDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.
Cheng-Mao LinDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.
Margaret Elizabeth RossDepartment of Neurology, Weill Cornell Medical College, New York, NY.
Morgan E DeSantisDepartment of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, MI.ORCID 0000-0002-4096-8548
Daniel A LawrenceDepartment of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, MI.
David A AntonettiDepartment of Ophthalmology and Visual Science, University of Michigan School of Medicine, Ann Arbor, MI.

Funding

Regional Pilot And Feasibility Study Grants ProgramP30DK020572 · NIDDK · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Mehboob A Hussain · 2013 to 2026
$24.3M
VIVARIUM MODULEP30EY007003 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti · 1987 to 2026
$17.6M
Unraveling the role of tPA in the neurovascular unitR01HL055374 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI David Antonetti, Daniel A Lawrence · 1995 to 2026
$8.6M
MECHANISMS OF RETINAL VASCULAR PERMEABILITY IN DIABETESR01EY012021 · NEI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTONETTI, DAVID · 1998 to 2024
$8.6M
Leica SP8 Confocal MicroscopeS10OD028612 · OD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ANTONETTI, DAVID · 2021 to 2021
$599k
NEI NIH HHS P30 EY007003NEI NIH HHS R01 EY012021NHLBI NIH HHS R01 HL055374NIDDK NIH HHS P30 DK020572NIH HHS S10 OD028612
6 · The paper itself

Abstract

Previous studies of the tight junction protein occludin (OCLN) suggest that multiple phosphorylation sites on the carboxy-terminal domain contribute a regulatory role in vascular barrier properties. However, gene deletion studies failed to identify a clear functional role for OCLN, despite multiple phenotypic alterations. Importantly, previous studies targeting exon 3 allowed expression of a splice variant starting at exon 4, (isoform 4) that expresses the full carboxy-terminal tail. Here we show that the OCLN carboxy-terminus forms a complex with the light intermediate chain (LIC) of dynein to link tight junction cargo to the minus end directed motor protein. Mutational analysis revealed S471 phosphorylation is required for binding to the LIC while S490 phosphorylation is required for trafficking. Expressing

Indexed as

AngiogenesisDiabetic RetinopathyStrokeTight JunctionsVascular Permeability

Identifiers

PMID40661615
PMCPMC12259183

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.